A pilot study of tofacitinib for refractory Behçet’s syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-217307
Abstract: Behcet’s syndrome (BS) is a chronic inflammatory disease characterised by recurrent oral and genital ulcers, frequently complicated with uveitis gastrointestinal, neurological, major vessel and cardiac involvement. For severe and (or) refractory BS, tumour necrosis factor… read more here.
Keywords: tofacitinib refractory; pilot study; disease; study tofacitinib ... See more keywords